Adviser Investments LLC Novo Nordisk A S Transaction History

Adviser Investments LLC

$8.03 Billion
Q4 2024

A detailed history of Adviser Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Adviser Investments LLC holds 90,823 shares of NVO stock, worth $8.23 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

90,823

Previous 61,036 48.8%

Holding current value

$8.23 Million

Previous $7.27 Million 7.5%

% of portfolio

0.1%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$85.0 - $120.04 $2.53 Million - $3.58 Million	29,787 Added 48.8%	90,823 $7.81 Million
Q3 2024 Nov 08, 2024	SELL	$119.07 - $145.42 $2.68 Million - $3.28 Million	-22,537 Reduced 26.97%	61,036 $7.27 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $532,561 - $637,589	-4,340 Reduced 4.94%	83,573 $11.9 Million
Q1 2024 Apr 29, 2024	SELL	$102.11 - $135.92 $499,624 - $665,056	-4,893 Reduced 5.27%	87,913 $11.3 Million
Q4 2023 Feb 01, 2024	BUY	$87.78 - $105.45 $6.4 Million - $7.69 Million	72,924 Added 366.78%	92,806 $9.6 Million
Q3 2023 Oct 11, 2023	BUY	$90.94 - $199.54 $1.81 Million - $3.97 Million	19,882 New	19,882 $1.81 Million
Q2 2022 Jul 14, 2022	SELL	$103.24 - $121.81 $13,008 - $15,348	-126 Reduced 1.28%	9,734 $1.09 Million
Q4 2021 Jan 31, 2022	SELL	$95.88 - $117.08 $59,637 - $72,823	-622 Reduced 5.93%	9,860 $1.1 Million
Q3 2021 Nov 05, 2021	SELL	$84.42 - $106.62 $43,391 - $54,802	-514 Reduced 4.67%	10,482 $1.01 Million
Q2 2021 Jul 09, 2021	SELL	$67.66 - $84.76 $5,818 - $7,289	-86 Reduced 0.78%	10,996 $921,000
Q1 2021 May 05, 2021	BUY	$67.06 - $75.82 $14,216 - $16,073	212 Added 1.95%	11,082 $747,000
Q4 2020 Jan 26, 2021	BUY	$63.89 - $73.8 $39,739 - $45,903	622 Added 6.07%	10,870 $759,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $891 - $983	14 Added 0.14%	10,248 $711,000
Q1 2020 Apr 08, 2020	SELL	$49.46 - $64.78 $24,730 - $32,390	-500 Reduced 4.66%	10,234 $616,000
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $24,930 - $29,130	500 Added 4.89%	10,734 $621,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $23,770 - $26,715	-500 Reduced 4.66%	10,234 $529,000
Q4 2018 Jan 25, 2019	SELL	$41.54 - $47.25 $11,423 - $12,993	-275 Reduced 2.5%	10,734 $494,000
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $14,547 - $17,442	-300 Reduced 2.65%	11,009 $542,000
Q4 2017 Feb 12, 2018	BUY	$47.53 - $53.73 $23,765 - $26,865	500 Added 4.63%	11,309 $607,000
Q3 2017 Oct 23, 2017	BUY	$41.15 - $49.22 $444,790 - $532,018	10,809	10,809 $520,000

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Account

Adviser Investments LLC Novo Nordisk A S Transaction History